For instance, in autoimmune diseases such as SLE and RA, MIF levels correlate with disease severity, and in cancers, including colorectal cancer, high MIF levels are linked to poor patient outcomes (173, 175). This evidence concerns the gene MIF and rheumatoid arthritis.